InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

COMPUGEN LTD

CGEN Clue Score73
Israel Fiscal year ends December CIK 0001119774
$2.13 +0.47% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.13 −64.85% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.7Operating income−32.6Net income−31.5EPS, diluted−0.62Fiscal year 2017Operating income−37.4Net income−37.1EPS, diluted−0.72Fiscal year 2018Revenue17.8Operating income−23.2Net income−22.6EPS, diluted−0.41Fiscal year 2019Operating income−28.9Net income−27.3EPS, diluted−0.43Fiscal year 2020Revenue2.0Operating income−31.5Net income−29.7EPS, diluted−0.37Fiscal year 2021Revenue6.0 +200.0%Operating income−35.1Net income−34.2EPS, diluted−0.41Fiscal year 2022Revenue7.5 +25.0%Operating income−35.4Net income−33.7EPS, diluted−0.39Fiscal year 2023Revenue33.5 +346.1%Operating income−13.0Net income−18.8EPS, diluted−0.21Fiscal year 2024Revenue27.9 −16.7%Operating income−14.9Net income−14.2EPS, diluted−0.16Fiscal year 2025Revenue72.8 +161.1%Operating income31.3Net income35.3EPS, diluted0.38
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.7 n/a 17.8 n/a 2.0 6.0 7.5 33.5 27.9 72.8
Growth +200.0% +25.0% +346.1% −16.7% +161.1%
Operating income −32.6 −37.4 −23.2 −28.9 −31.5 −35.1 −35.4 −13.0 −14.9 31.3
Net income −31.5 −37.1 −22.6 −27.3 −29.7 −34.2 −33.7 −18.8 −14.2 35.3
Growth
EPS, diluted −0.62 −0.72 −0.41 −0.43 −0.37 −0.41 −0.39 −0.21 −0.16 0.38
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin68.7%Operating margin−4,576.3%Net margin−4,425.0%Free cash flow margin−3,148.6%Fiscal year 2017Fiscal year 2018Gross margin94.2%Operating margin−130.5%Net margin−127.0%Free cash flow margin−75.6%Fiscal year 2019Fiscal year 2020Gross margin97.0%Operating margin−1,574.8%Net margin−1,484.9%Free cash flow margin−1,424.3%Fiscal year 2021Gross margin88.7%Operating margin−584.6%Net margin−570.1%Free cash flow margin−383.0%Fiscal year 2022Gross margin87.0%Operating margin−471.7%Net margin−449.3%Free cash flow margin−461.2%Fiscal year 2023Gross margin94.0%Operating margin−38.8%Net margin−56.1%Free cash flow margin−107.8%Fiscal year 2024Gross margin71.5%Operating margin−53.4%Net margin−51.1%Free cash flow margin177.6%Fiscal year 2025Gross margin87.3%Operating margin43.1%Net margin48.6%Free cash flow margin43.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 68.7% n/a 94.2% n/a 97.0% 88.7% 87.0% 94.0% 71.5% 87.3%
Operating margin −4,576.3% n/a −130.5% n/a −1,574.8% −584.6% −471.7% −38.8% −53.4% 43.1%
Net margin −4,425.0% n/a −127.0% n/a −1,484.9% −570.1% −449.3% −56.1% −51.1% 48.6%
Free cash flow margin −3,148.6% n/a −75.6% n/a −1,424.3% −383.0% −461.2% −107.8% 177.6% 43.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−19.8Capital expenditure−2.6Free cash flow−22.4Fiscal year 2017Operating cash flow−30.7Capital expenditure−0.4Free cash flow−31.0Fiscal year 2018Operating cash flow−13.3Capital expenditure−0.2Free cash flow−13.4Fiscal year 2019Operating cash flow−27.9Capital expenditure−0.2Free cash flow−28.0Fiscal year 2020Operating cash flow−28.3Capital expenditure−0.2Free cash flow−28.5Fiscal year 2021Operating cash flow−22.7Capital expenditure−0.3Free cash flow−23.0Fiscal year 2022Operating cash flow−34.1Capital expenditure−0.5Free cash flow−34.6Fiscal year 2023Operating cash flow−35.9Capital expenditure−0.2Free cash flow−36.1Fiscal year 2024Operating cash flow49.6Capital expenditure−0.1Free cash flow49.5Fiscal year 2025Operating cash flow31.6Capital expenditure−0.3Free cash flow31.3 −36.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −19.8 −30.7 −13.3 −27.9 −28.3 −22.7 −34.1 −35.9 49.6 31.6
Capital expenditure −2.6 −0.4 −0.2 −0.2 −0.2 −0.3 −0.5 −0.2 −0.1 −0.3
Free cash flow −22.4 −31.0 −13.4 −28.0 −28.5 −23.0 −34.6 −36.1 49.5 31.3
Growth −36.7%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash9.7Shareholders’ equity63.5Fiscal year 2017Cash25.5Shareholders’ equity29.3Fiscal year 2018Cash5.9Shareholders’ equity37.2Fiscal year 2019Cash9.2Shareholders’ equity38.3Fiscal year 2020Cash7.1Shareholders’ equity119.8Fiscal year 2021Cash7.8Shareholders’ equity106.7Fiscal year 2022Cash11.1Shareholders’ equity77.7Fiscal year 2023Cash13.9Shareholders’ equity65.6Fiscal year 2024Cash18.2Shareholders’ equity54.9Fiscal year 2025Cash90.6Shareholders’ equity102.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 9.7 25.5 5.9 9.2 7.1 7.8 11.1 13.9 18.2 90.6
Shareholders’ equity 63.5 29.3 37.2 38.3 119.8 106.7 77.7 65.6 54.9 102.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.7 n/a 17.8 n/a 2.0 6.0 7.5 33.5 27.9 72.8
Growth +200.0% +25.0% +346.1% −16.7% +161.1%
0.2 n/a 1.0 n/a 0.1 0.7 1.0 2.0 7.9 9.3
0.5 n/a 16.8 n/a 1.9 5.3 6.5 31.5 19.9 63.5
Growth +174.2% +22.7% +382.1% −36.6% +218.6%
24.5 28.6 30.3 19.8 22.8 28.7 30.6 34.5 24.8 22.8
7.3 7.6 8.0 8.4 9.8 10.9 10.3 9.7 9.4 8.9
−32.6 −37.4 −23.2 −28.9 −31.5 −35.1 −35.4 −13.0 −14.9 31.3
Growth
−31.5 −37.1 −22.6 −28.1 −29.7 −34.2 −33.6 −9.8 −9.7 35.4
0.0 n/a n/a −0.7 0.0 0.0 0.1 9.0 4.5 0.1
−31.5 −37.1 −22.6 −27.3 −29.7 −34.2 −33.7 −18.8 −14.2 35.3
Growth
Per share
−0.62 −0.72 −0.41 −0.43 −0.37 −0.41 −0.39 −0.21 −0.16 0.38
−0.62 −0.72 −0.41 −0.43 −0.37 −0.41 −0.39 −0.21 −0.16 0.38
Growth
50.9 51.2 55.3 63.6 79.6 84.2 86.6 87.6 89.5 93.4
50.9 51.2 55.3 63.6 79.6 84.2 86.6 87.6 89.5 93.8
Growth +0.6% +8.0% +15.1% +25.1% +5.8% +2.8% +1.2% +2.2% +4.8%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 105.2% a year over five years.
  • The diluted share count rose 17.9% in five years, which is dilution.
  • Operating margin is up 1,617.9 points on five years ago, at 43.1%.
  • A net loss in 9 of 10 years on file.